TickerFacts.

Omada Health, Inc. (OMDA): Cost of Revenue

Annual figures by period end, from SEC filings.

$89.27M
Year ended 2025-12-31
$98.55M
Trailing 12 months to 2026-06-30
2023-12-31: $52.81M2024-12-31: $66.92M2025-12-31: $89.27M$89.27M
2023-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$89.27M+33.4%2026-03-06, From 2025-01-01
2024-12-31$66.92M+26.7%2026-03-06, From 2024-01-01
2023-12-31$52.81Mn/a2026-03-06, From 2023-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Services-Health Services), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Omada Health, Inc. (OMDA)2025-12-31$89.27M+33.4%
Strata Critical Medical, Inc. (SRTA)2025-12-31$156.01M+33.1%
GeneDx Holdings Corp. (WGS)2025-12-31$129.37M+16.5%
Vsee Health, Inc. (VSEE)2025-12-31$7.26M+123.9%
EUDA Health Holdings Ltd (EUDA)2025-12-31$3.83M+17.8%
Longduoduo Co Ltd (LDDD)2025-06-30$91.1K-47.4%
Agape ATP Corp (ATPC)2025-12-31$686.0K+21.7%

Compare OMDA, SRTA, WGS, VSEE side by side · Screen every company in Services-Health Services ↗